Investigator

Paulo Cilas Morais Lyra

Machine Learning Software Engineer · Moffitt Cancer Center, Machine Learning

PCMPaulo Cilas Morai…
Papers(1)
Functional evaluation…
Collaborators(10)
Steven N. HartSusan M DomchekWenan ChenAlvaro N MonteiroChaitanya BandlamudiChunling HuDiana L. MandelkerFergus J. CouchHuaizhi HuangJie Na
Institutions(5)
Moffitt Cancer CenterMayo ClinicUniversity of Pennsyl…Mayo ClinicMemorial Sloan Ketter…

Papers

Functional evaluation and clinical classification of BRCA2 variants

Germline BRCA2 loss-of function variants, which can be identified through clinical genetic testing, predispose to several cancers

1Papers
15Collaborators
Genetic Predisposition to DiseaseBreast NeoplasmsPancreatic NeoplasmsBiomarkers, TumorTumor Suppressor Protein p53Ovarian NeoplasmsTriple Negative Breast Neoplasms

Positions

2024–

Machine Learning Software Engineer

Moffitt Cancer Center · Machine Learning

2022–

Postdoc

Moffitt Cancer Center · Population Science

2018–

Postdoc

Federal University of Espírito Santo · Biotechnology

2018–

Oncological Pharmacist

Evangélico de Vila Velha Hospital · Oncology

2017–

Pharmacist

Dr. Jayme Santos Neves Hospital · Pharmacy

2012–

Professor

Federal University of Espirito Santo · Pharmacy

Education

2018

PhD

Federal University of Espírito Santo · Biotechnology

2013

MSc

Federal University of Espirito Santo · Biotechnology

2011

Bachelor of Pharmacy

EMESCAM · Pharmacy

Country

BR

Links & IDs
0000-0002-4403-6684

Scopus: 57193727033